Literature DB >> 4228177

[On 2-benzolsulfonylamino-5(beta-methoxy-ethoxy)-pyrimidine (glycodiazine. V. In vitro and in vivo experiments on the action of phenylethylbarbituric acid (Luminal) on the metabolism and blood sugar reducing effect of glycodiazine].

E Gerhards, K H Kolb, P E Schulze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4228177

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol        ISSN： 0365-5423


× No keyword cloud information.
  19 in total

1.  THE LIGHT REVERSIBLE CARBON MONOXIDE INHIBITION OF THE STEROID C21-HYDROXYLASE SYSTEM OF THE ADRENAL CORTEX.

Authors:  R W ESTABROOK; D Y COOPER; O ROSENTHAL
Journal:  Biochem Z       Date:  1963

2.  [ACCELERATED DRUG DEGRADATION BY ENZYME INDUCTION IN DOGS AFTER TREATMENT WITH PHENOBARBITAL].

Authors:  H REMMER; M SIEGERT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

3.  [INCREASE IN DRUG OXIDIZING ENZYME ACTIVITY WITH TOLBUTAMIDE].

Authors:  H REMMER; M SIEGERT; H J MERKER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-10-02

4.  [Enzyme induction and increase of endoplasmic reticulum in liver cells during phenobarbital (Luminal) therapy].

Authors:  H REMMER; H J MERKER
Journal:  Klin Wochenschr       Date:  1963-03-15

5.  Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

Authors:  A H CONNEY; C DAVISON; R GASTEL; J J BURNS
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

6.  [Paper chromatography of aliphatic dicarboxylic acids].

Authors:  H KALBE
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1954

7.  Effects of 3-methylcholanthrene and phenobarbital on amino acid incorporation into protein.

Authors:  H V GELBOIN; L SOKOLOFF
Journal:  Science       Date:  1961-09-01       Impact factor: 47.728

8.  [On benzenesulfonylamino-5-[beta-methoxyethoxy]-pyrimidine (glycodiazine). 3. Glycodiazine plasma concentration and blood sugar lowering effects in humans, as well as the influence of glycodiazine on the hypophyseal-adrenal cortex system].

Authors:  E Gerhards; H Gibian; K H Kolb
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1965

9.  [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING AGENT. I. THE METABOLISM OF GLYCODIAZIN IN MAN].

Authors:  E GERHARDS; H GIBIAN; K H KOLB
Journal:  Arzneimittelforschung       Date:  1964-05

10.  [RESORPTION, DISTRIBUTION AND EXCRETION OF RADIOACTIVE-LABELLED 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN ANIMAL EXPERIMENTS].

Authors:  K H KOLB; M KRAMER; P E SCHULZE
Journal:  Arzneimittelforschung       Date:  1964-05
View more
  2 in total

1.  [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].

Authors:  H Held; B Kaminski; H F von Oldershausen
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

2.  The comparative effects of barbituric acid phenobarbital on blood glucose and insulin secretion in mice.

Authors:  J H Mennear; C Schonwalder; E T Yau
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.